A detailed history of Quest Partners LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 10,668 shares of IDYA stock, worth $251,658. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,668
Previous 27,431 61.11%
Holding current value
$251,658
Previous $449 Million 50.09%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

SELL
$14.5 - $22.63 $243,063 - $379,346
-16,763 Reduced 61.11%
10,668 $224 Million
Q1 2025

May 14, 2025

BUY
$16.38 - $26.0 $323,832 - $514,020
19,770 Added 258.06%
27,431 $449 Million
Q4 2024

Feb 07, 2025

SELL
$24.79 - $31.98 $654,480 - $844,303
-26,401 Reduced 77.51%
7,661 $197 Million
Q3 2024

Nov 07, 2024

BUY
$30.37 - $43.05 $998,687 - $1.42 Million
32,884 Added 2791.51%
34,062 $1.08 Billion
Q2 2024

Aug 06, 2024

BUY
$34.37 - $43.46 $40,487 - $51,195
1,178 New
1,178 $41.4 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.13B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.